255
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The relationship between weight change and inflammatory bowel disease. A population-based cohort study, the HUNT study

, , ORCID Icon, & ORCID Icon
Received 14 Feb 2024, Accepted 05 May 2024, Published online: 13 May 2024

References

  • Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42. doi: 10.1053/j.gastro.2011.10.001.
  • Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi: 10.1038/nrgastro.2015.150.
  • Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91–99. doi: 10.3748/wjg.v20.i1.91.
  • Turpin W, Goethel A, Bedrani L, et al. Determinants of IBD heritability: genes, bugs, and more. Inflamm Bowel Dis. 2018;24(6):1133–1148. doi: 10.1093/ibd/izy085.
  • Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6(5):339–346.
  • Sterry W, Strober BE, Menter A, International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007;157(4):649–655. doi: 10.1111/j.1365-2133.2007.08068.x.
  • Qin B, Yang M, Fu H, et al. Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis. Arthritis Res Ther. 2015;17(1):86. doi: 10.1186/s13075-015-0601-x.
  • Winer DA, Luck H, Tsai S, et al. The intestinal immune system in obesity and insulin resistance. Cell Metab. 2016;23(3):413–426. doi: 10.1016/j.cmet.2016.01.003.
  • Poullis A, Foster R, Shetty A, et al. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13(2):279–284. doi: 10.1158/1055-9965.epi-03-0160.
  • Kim JH, Heo JS, Baek KS, et al. Zonulin level, a marker of intestinal permeability, is increased in association with liver enzymes in young adolescents. Clin Chim Acta. 2018;481:218–224. doi: 10.1016/j.cca.2018.03.005.
  • Obesity and overweight. Accessed September 4, 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
  • Singh S, Dulai PS, Zarrinpar A, et al. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14(2):110–121. doi: 10.1038/nrgastro.2016.181.
  • Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT study, Norway. Int J Epidemiol. 2013;42(4):968–977. doi: 10.1093/ije/dys095.
  • Jakobsson GL, Sternegård E, Olén O, et al. Validating inflammatory bowel disease (IBD) in the swedish national patient register and the swedish quality register for IBD (SWIBREG). Scand J Gastroenterol. 2017;52(2):216–221. doi: 10.1080/00365521.2016.1246605.
  • Chan SSM, Chen Y, Casey K, et al. Obesity is associated with increased risk of crohn’s disease, but not ulcerative colitis: a pooled analysis of five prospective cohort studies. Clin Gastroenterol Hepatol. 2021;20(5):1048–1058. doi: 10.1016/j.cgh.2021.06.049.
  • Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Measures of obesity and risk of crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2015;21(2):361–368. doi: 10.1097/MIB.0000000000000283.